CA1322521C - Composition analogue a l'hormone liberant la thyrotropine et utilisation de ladite compostion - Google Patents

Composition analogue a l'hormone liberant la thyrotropine et utilisation de ladite compostion

Info

Publication number
CA1322521C
CA1322521C CA000568592A CA568592A CA1322521C CA 1322521 C CA1322521 C CA 1322521C CA 000568592 A CA000568592 A CA 000568592A CA 568592 A CA568592 A CA 568592A CA 1322521 C CA1322521 C CA 1322521C
Authority
CA
Canada
Prior art keywords
thyrotropin
releasing hormone
hormone analog
patient
prolineamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000568592A
Other languages
English (en)
Inventor
Alan I. Faden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Medicis Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicis Pharmaceutical Corp filed Critical Medicis Pharmaceutical Corp
Application granted granted Critical
Publication of CA1322521C publication Critical patent/CA1322521C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/066—TRH, thyroliberin, thyrotropin releasing hormone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000568592A 1987-06-05 1988-06-03 Composition analogue a l'hormone liberant la thyrotropine et utilisation de ladite compostion Expired - Fee Related CA1322521C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5838087A 1987-06-05 1987-06-05
US058,380 1987-06-05

Publications (1)

Publication Number Publication Date
CA1322521C true CA1322521C (fr) 1993-09-28

Family

ID=22016452

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000568592A Expired - Fee Related CA1322521C (fr) 1987-06-05 1988-06-03 Composition analogue a l'hormone liberant la thyrotropine et utilisation de ladite compostion

Country Status (4)

Country Link
EP (1) EP0317613A1 (fr)
JP (1) JPH01503465A (fr)
CA (1) CA1322521C (fr)
WO (1) WO1988009606A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5458822A (en) * 1993-06-21 1995-10-17 Owens-Corning Fiberglas Technology, Inc. Method for manufacturing a mineral fiber product

Also Published As

Publication number Publication date
WO1988009606A2 (fr) 1988-12-15
EP0317613A1 (fr) 1989-05-31
JPH01503465A (ja) 1989-11-22

Similar Documents

Publication Publication Date Title
KR100638684B1 (ko) 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
EP0261429B1 (fr) Systèmes augmentant le pouvoir pénétrant et leur préparation
KR100248030B1 (ko) 시토킨 조절제 및 시토킨 농도 변화에 관련된 병변 및 질환에 있어서 그의 용도
US4444758A (en) Nonapeptide for treating addictive drug withdrawal conditions
CA2376978A1 (fr) Compositions et methodes de traitement de dysfonctionnements sexuels
CA2070685C (fr) Methode de traitement des affections douloureuses, inflammatoires ou allergiques
US20120083452A1 (en) Topical Anesthetic Uses of Szeto-Schiller Peptides
JP2001500876A (ja) 液体形態の改良された安定性を有するコルチコトロピン放出因子の医薬製剤
CA2038597A1 (fr) Methode et preparation pharmaceutique pour le soulagement de la douleur
JPS62116510A (ja) 神経再生のための新規な医薬組成物
EP0317624B1 (fr) Utilisation d'analogues de l'hormone de liberation de la thyrotropine pour le traitement des lesions du systeme nerveux central
CA1322521C (fr) Composition analogue a l'hormone liberant la thyrotropine et utilisation de ladite compostion
US5686420A (en) Thyrotropin-releasing hormone analogs and method of use
FR2556216A1 (fr) Nouveau medicament analgesique contenant du proglumide, eventuellement en association avec des medicaments analgesiques-narcotiques
EP0213676B1 (fr) Compositions pharmaceutiques contenant l'ACTH(1-24)pour la thérapie des états de choc et des insuffisances respiratoires et cardiocirculatoires
JPH10504279A (ja) ウイルス感染症及び場合により炎症の予防及び／又は治療用医薬組成物並びにそれらの治療方法
JP2002532422A (ja) ドラメクチン製剤
US4666926A (en) Transdermal formulations
HU223205B1 (hu) Helyileg alkalmazható készítmény peptidszerű gyógyhatású vegyületek élő szervezetbe vitelére
FR2485374A1 (fr) Peptides a activite biologique
OZAWA et al. Sites of action of crystalline tetrodotoxin on sympathetic nervous systems
US4794104A (en) Pharmaceutical compositions containing ACTH fragments for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
USRE32990E (en) Use of undercylenic acid to treat herpes labialis
GB2189703A (en) Vinpocetine
WO1995023580A1 (fr) Prevention et traitement de la depilation secondaire

Legal Events

Date Code Title Description
MKLA Lapsed